- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Swedish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
1 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
BIOA B New | SEK 212.80 | 23.9% | -21.2% | SEK 18.8b | SEK 322.00 | PS112.5x | E62.5% | 0% | ||
BONEX | SEK 382.00 | 8.0% | 108.7% | SEK 25.1b | SEK 402.33 | PE277.5x | E72.2% | n/a |
Page 1 of 1